By Mark Schoeman One of Clear Point Health’s core lines of business is engaging key opinion leaders (KOLs) on behalf of pharmaceutical companies, to glean their insights on a variety of subjects. One of the most important areas of our research centers on optimizing relationships between KOLs and those who serve as their primary contacts …
The Exchange of Scientific Information During COVID-19, Part 2: Content Read More »
By Mark Schoeman At this point, in the midst of a global pandemic, both medical science liaisons (MSLs) and commercial sales representatives are virtually unable to engage anyone face-to-face. This represents a significant shift, as face-to-face engagement has long been the bread and butter for most pharma representatives on both the medical and sales sides …
The Exchange of Scientific Information During COVID-19, Part 1: Channel Read More »
By Sima Marzban, MD, PhD, MPH The relationships between patients and healthcare providers and intermediaries (healthcare providers, manufacturers, and insurers) have been transformed in recent years based on the patient-centered paradigm, where patients are expected to play an active role in their health and wellness. Patient engagement is based on the principle that providers work …
By Paul Meade Long gone are the days when you could walk into a medical practice, and get a ten-minute meeting with a physician to discuss your company’s pharmaceutical offerings. The COVID-19 pandemic has completely changed the way we interact with each other, and many medical science liaisons (MSLs) are slow to adapt to this …
Virtual Engagement: The New Normal of Video Conferencing Read More »
By Mark Schoeman When this pandemic began, we understood that it was going to have a significant impact on the pharmaceutical industry, but we’re just now realizing the full impact. Clear Point Health created and distributed a survey to key opinion leaders (KOLs) in medicine, and we received one hundred and twenty responses from healthcare …
By Paul Meade, M.Sc, MPH In any scenario planning situation, you start by looking at the macro-drivers of change. In other words, what’s happening in the world that is driving change? Before you can come up with potential scenarios, you have to understand what’s changing in a number of areas: the political environment, the economic environment, …
Macro-Drivers of Change: What Will Become “The New Normal” After COVID-19 Read More »
By Paul Meade, M.Sc, MPH Those of us in the healthcare community always believed that there was going to be another pandemic. But the pandemic we’re experiencing now, COVID-19, is a different kind of bug to what we’ve studied historically. Two major factors set this virus apart: first, it’s a coronavirus rather than an influenza …
Clear Point Health is proud to announce a new podcast aimed at educating healthcare stakeholders like hospitals and life sciences companies in the study of customer experience (CX) and engagement. Clear Points marks its debut episode on the Parklife Podcast Network, out now on Soundcloud, Spotify, and Apple Podcasts. In the inaugural show, host Brian …
Clear Point Health Launches New Healthcare CX Podcast: Clear Points Read More »
By Brian Castle Over the last decade, healthcare providers have been consolidating at breakneck pace. A variety of factors have fueled the rise of so-called health systems (also known in various permutations as integrated delivery networks, accountable care organizations, hospital systems, and more) rising costs, competitive forces, and the advance of regulation like the Affordable …
Rise of Health Systems Poses Engagement Challenges for Industry Read More »
by Kristen Smithwick Value-based care promises to deliver better healthcare for less money. For years, US healthcare providers and institutions have received payments for care services rendered. This fee-for-service model unintentionally encouraged behaviors that might not have been the best for patients – from seeing more patients per day to ordering tests and procedures that may …
Chasing Value-Based Care: Why Does It Remain Elusive? Read More »
